REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/04/2026
Back to search
Official data from USPTO
ATROPINE SULFATE OPHTHALMIC SOLUTION 0.01% OMNI BY OSRX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
05/05/2026
Trademark type
Combined
Nice classes
5
Filing date
05/09/2019
Registration date
05/04/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/04/2021
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/01/2019
First use in commerce
05/01/2019
Drawing code
3
Owner type
03
Owner location
Missoula, MT, US
Examiner
DETMER, CAROLYN ROSE
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "ATROPINE SULFATE OPTHALMIC SOLUTION 0.01%" above the words of "OMNI BY OSRX". The "ATROPINE SULFATE OPTHALMIC SOLUTION" words are above the "0.01%" language. The word "OMNI" is above the words "BY OSRX". The lettering for "OMNI" is larger than the lettering for "BY OSRX". There is a shaded circle behind most of the letter "M" in "OMNI". There is a top arc that begins between the "O" and the "M" of "OMNI" and arcs towards the right ending to the right of the "I" in "OMNI" and ending to the right of the "X" in "OSRX". There is a bottom arc that begins at the "N" in "OMNI" and then arcs towards the left ending to the left of the "O" in "OMNI".
Holders and representatives
Holders
OSRX, Inc.
Representatives
Brendan J. Hughes Cooley LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Ophthalmic preparations containing atropine sulfate
Publications
History of USPTO decisions and trademark events.
41 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/21/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/21/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/21/2025
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
03/10/2025
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
03/10/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/04/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/30/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/29/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/26/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/26/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/06/2020
GNRT
NON-FINAL ACTION E-MAILED
10/06/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/06/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/02/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/02/2020
IUAF
USE AMENDMENT FILED
09/17/2020
EISU
TEAS STATEMENT OF USE RECEIVED
09/17/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/28/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/02/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/02/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/02/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/02/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/02/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2020
PUBO
PUBLISHED FOR OPPOSITION
03/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/29/2020
ALIE
ASSIGNED TO LIE
01/29/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/24/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/23/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/22/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/22/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/25/2019
GNRT
NON-FINAL ACTION E-MAILED
07/25/2019
CNRT
NON-FINAL ACTION WRITTEN
07/25/2019
DOCK
ASSIGNED TO EXAMINER
07/24/2019
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/25/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/24/2019
NWAP
NEW APPLICATION ENTERED
05/13/2019
Continuous trademark protection
Get notified about every new filing that threatens ATROPINE SULFATE OPHTHALMIC SOLUTION 0.01% OMNI BY OSRX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.